Jiangsu Deyuan Pharmaceutical Co (BJSE:920735) Total Current Assets: ¥981 Mil (As of Jun. 2026)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Jiangsu Deyuan Pharmaceutical Co Ltd BJSE:920735

97 GF Score

Price ¥26.66

GF Value ¥29.61

Valuation Modestly Undervalued

2 Warning Signs

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

What is Jiangsu Deyuan Pharmaceutical Co Total Current Assets?

Jiangsu Deyuan Pharmaceutical Co BJSE:920735 97 Total Current Assets is ¥981 Mil as of Jun. 2026. GuruFocus rates BJSE:920735 with a GF Score™ of 97/100 and a GF Value™ of ¥29.61 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Jiangsu Deyuan Pharmaceutical Co's total current assets for the quarter that ended in Jun. 2026 was ¥981 Mil.

Try GuruFocus Premium free for 7 days

Unlock GF Score, GF Value, 30-Y financials, and pro screeners.

Get Started →

Jiangsu Deyuan Pharmaceutical Co (BJSE:920735) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Jiangsu Deyuan Pharmaceutical Co's Liquidation Value for the quarter that ended in Jun. 2026 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	505.09	-	321.972	+	0.75 * 220.109	+	0.5 * 104.61
=	401

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangsu Deyuan Pharmaceutical Co Total Current Assets Related Terms

Jiangsu Deyuan Pharmaceutical Co Total Current Assets Historical Data

* Premium members only.

The historical data trend for Jiangsu Deyuan Pharmaceutical Co's Total Current Assets can be seen below:

Jiangsu Deyuan Pharmaceutical Co Total Current Assets Chart

Jiangsu Deyuan Pharmaceutical Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Current Assets

Get a 7-Day Free Trial

616.69

728.99

785.39

789.43

859.48

Jiangsu Deyuan Pharmaceutical Co Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26	Jun26
Total Current Assets	Get a 7-Day Free Trial															802.25	836.50	859.48	935.33	980.86

97GF Score

Jiangsu Deyuan Pharmaceutical Co Ltd BJSE:920735

Total Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

Jiangsu Deyuan Pharmaceutical Co Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Jiangsu Deyuan Pharmaceutical Co's Total Current Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	469.952	+	242.84	+	81.502	+	65.19
	=	859

Jiangsu Deyuan Pharmaceutical Co's Total Current Assets for the quarter that ended in Jun. 2026 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	505.09	+	317.218	+	104.61	+	53.946
	=	981

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →

What does a Total Current Assets of ¥981 Mil mean?

Jiangsu Deyuan Pharmaceutical Co (BJSE:920735) has a Total Current Assets of ¥981 Mil as of Jun. 2026. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Jiangsu Deyuan Pharmaceutical Co and its competitors.

Is Jiangsu Deyuan Pharmaceutical Co's Total Current Assets too high?

Jiangsu Deyuan Pharmaceutical Co's current Total Current Assets is ¥981 Mil. Overall, Jiangsu Deyuan Pharmaceutical Co has a GF Score™ of 97/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Jiangsu Deyuan Pharmaceutical Co's Total Current Assets compare to ZTS?

Jiangsu Deyuan Pharmaceutical Co's Total Current Assets of ¥981 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Current Assets for a Drug Manufacturers company?

A good Total Current Assets depends on the Drug Manufacturers industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Current Assets mean?

A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Jiangsu Deyuan Pharmaceutical Co and its competitors. Jiangsu Deyuan Pharmaceutical Co's current Total Current Assets is ¥981 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Jiangsu Deyuan Pharmaceutical Co stock overvalued right now?

Based on GuruFocus' analysis, Jiangsu Deyuan Pharmaceutical Co (BJSE:920735) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥29.61, compared to a current price of ¥26.66 — trading 10% below its estimated fair value. The current Total Current Assets is ¥981 Mil. Jiangsu Deyuan Pharmaceutical Co's overall GF Score™ is 97/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Current Assets calculated?

Total Current Assets is calculated from a company's financial statements. For Jiangsu Deyuan Pharmaceutical Co (BJSE:920735), the current Total Current Assets is ¥981 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jiangsu Deyuan Pharmaceutical Co (BJSE:920735) Overvalued in 2026?

Based on GuruFocus' analysis, Jiangsu Deyuan Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥26.66 is trading 10% below its estimated GF Value™ of ¥29.61. GuruFocus considers Jiangsu Deyuan Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for BJSE:920735:

Total Current Assets: ¥981 Mil
GF Value™: ¥29.61 vs. price of ¥26.66 (10% below fair value)
GF Score™: 97/100 with 2 warning signs

No single metric tells the full story. See the BJSE:920735 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →